Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shen Qi Wen Fei prescription is a Traditional Chinese Medicine (TCM) herbal formula developed by The First Affiliated Hospital of Anhui University of Chinese Medicine. It is one of the components of the Xin'an Guben Peiyuan formula series, which is based on the Xin'an medical tradition for treating chronic obstructive pulmonary disease (COPD). The prescription is designed to tonify Qi and warm the lung, targeting specific TCM syndromes associated with stable COPD. In clinical research, it is typically administered orally as an adjunct to standard-of-care bronchodilator therapy, such as tiotropium, to evaluate its efficacy in improving lung function, reducing symptoms, and preventing exacerbations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shen Qi Wen Fei prescription.